Angus has 30 years in government, consulting, health, international development and in business. Roles included lead in AMR for Johnson & Johnson, where he created solutions to the AMR crisis with a focus on TB. He also spent 15 years with McKinsey & Company supporting African governments in multi-year transformation programs, including Sierra Leone during the Ebola crisis, Kenya on industrialization, Tanzania on government transformation, Ethiopia on education, and so on.

He has successfully managed 2 startups (in tech and non-profit), built the second-largest medical university in Tanzania, and spent five years as an executive with the Australian government.

CEO of ACHAP, Aranda’s partner; MD and former Deputy Permanent Secretary of the Ministry of Health in Botswana

Khumo is a member of the Botswana National AIDS Council, and Deputy Chairperson Country Coordinating Mechanism. Other board positions include Chair of the Food Control Board; member of Bureau of Standard Council, Health Professions Council; Botswana Harvard Partnership Board, and the Chemical Weapons Prohibition Board. She is Chair of the Health and HIV Component Coordination Group of the Government, UN Programme. A public health specialist in several units at the Princess Marina Hospital, as the CEO of ACHAP, Khumo oversees the expansion of ACHAP’s services in broader public health across southern Africa.

Former CEO, pharmaceutical executive, global health expert and professor

Jeff is the former CEO of Rabin Martin, a global health consultancy. He spent 20 years with Merck (MSD) as Vice President of External Affairs, Europe Middle East and Africa, was President of the Merck Company Foundation, and was President and CEO of the Global Health Council. He is Chairman of the Corporate Council on Africa.

Jeff developed several public-private partnerships including ACHAP in Botswana, and managed others including the Mectizan Donation Program. He has delivered over $750 million in product donations and humanitarian relief, and spent over 10 years building Merck’s policy initiatives for their businesses in Europe, the Middle East, Africa, Latin America and Canada.

30 years in finance, with a focus on the Development Finance Corporation

Paul has substantial experience securing Development Finance Institution funding of emerging market investments for projects in healthcare, housing, real estate, and manufacturing. He is President of Multi-National Strategies, and designed first debt-for-nature swap in Bolivia, advised on restructuring with IMF, World Bank, Paris Club creditors etc. In particular he was engaged by George Soros to assist governments in Eastern Europe with external debt restructuring, privatization, joint venture formation, and for Soros Fund Management, the first regional – and OPIC (DFC)-backed – private equity fund.